Henry Ford Health
Approved Enterprise Formulary
FormWeb QuickStart
Questions or Suggestions?
Pharmacy Shared Services Center
Search by name
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Biosimilar
Black Box Warning
Look Alike Sound Alike
Policy
REMS
Restricted Antimicrobials
Therapeutic Interchange
Hazardous Drugs
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
Boards
Brand name products with an equivalent generic may not be available to order at Henry Ford Health. For questions, contact inpatient pharmacy.
Henry Ford Health
Approved Enterprise Formulary
FormWeb QuickStart
Questions or Suggestions?
Pharmacy Shared Services Center
Search by name
Additional search options
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Biosimilar
Black Box Warning
Look Alike Sound Alike
Policy
REMS
Restricted Antimicrobials
Therapeutic Interchange
Hazardous Drugs
Search results for:
sofosbuvir-velpatasvir
sofosbuvir-velpatasvir
Drug Name
Form
Strength
Ambulatory Use Only
Ambulatory Restrictions
Inpatient Restrictions
Non-Formulary
Epclusa
TABLET, ORAL
400 mg-100 mg
Sofosbuvir-Velpatasvir
TABLET, ORAL
400 mg-100 mg
VIEW MORE
antiviral agents
,
antiviral combinations
CLASS
m00007
,
m00327
Last updated:
Dec. 17, 2025
Black Box Warning
Hepatitis B Virus Reactivation
Policy
Use of HCV Antibody Positive Lung Donors to HCV Negative Recipients
Policy
Use of HCV Antibody Positive Kidney Donors to HCV Negative Recipients
Policy
Use of HCV Antibody Positive Liver Donors to HCV Negative Recipients
Restricted Antimicrobials:
Criteria Monitored and Restricted Antimicrobials
Micromedex
Clinical Pharmacology
FDA DailyMed
UpToDate Lexidrug